Literature DB >> 8537333

JAK2, Ras, and Raf are required for activation of extracellular signal-regulated kinase/mitogen-activated protein kinase by growth hormone.

L A Winston1, T Hunter.   

Abstract

Protein-tyrosine kinases (PTKs) of the JAK family have been characterized on the basis of their ability to mediate the rapid induction of transcription of interferon-responsive genes through the stimulation of a class of latent cytoplasmic transcription factors known as signal transducers and activators of transcription (STATs). STAT activation, which has been described as being Ras-independent, requires tyrosine phosphorylation, but STAT transactivating activity is enhanced by phosphorylation on serine as well, probably by extracellular signal-regulated kinase/mitogen-activated protein kinase(s) (ERK/MAPK). STATs can be activated upon binding of ligands to receptor PTKs, to G-protein-linked receptors, and to cytokine receptors. Whether JAKs are required for the activation of signaling pathways other than that leading to STAT activation is not known. The binding of growth hormone (GH) to its receptor (GHR) activates JAK2 and STATs as well as ERK/MAP kinases. We have used a transient transfection system in 293 cells to evaluate the requirement for JAK2 in the activation of ERK2/MAPK by GH. We found that JAK2 is required for GH-simulated activation of ERK2/MAPK. Employing the transient expression of dominant negative forms of H-Ras and Raf-1, we determined that the GHR/JAK2-mediated activation of ERK2/MAPK is dependent on both Ras and Raf. Thus, JAK protein-tyrosine kinases may represent a common component in the activation of the ERK2/MAPK and STAT signaling pathways, which appear to bifurcate upstream of Ras activation but converge with ERK/MAPK phosphorylation of STATs.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8537333     DOI: 10.1074/jbc.270.52.30837

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

1.  Intratumoral mediated immunosuppression is prognostic in genetically engineered murine models of glioma and correlates to immunotherapeutic responses.

Authors:  Ling-Yuan Kong; Adam S Wu; Tiffany Doucette; Jun Wei; Waldemar Priebe; Gregory N Fuller; Wei Qiao; Raymond Sawaya; Ganesh Rao; Amy B Heimberger
Journal:  Clin Cancer Res       Date:  2010-10-04       Impact factor: 12.531

Review 2.  JAK2 inhibitors: what's the true therapeutic potential?

Authors:  Fabio P S Santos; Srdan Verstovsek
Journal:  Blood Rev       Date:  2010-11-20       Impact factor: 8.250

3.  Opposing actions of intact and N-terminal fragments of the human prolactin/growth hormone family members on angiogenesis: an efficient mechanism for the regulation of angiogenesis.

Authors:  I Struman; F Bentzien; H Lee; V Mainfroid; G D'Angelo; V Goffin; R I Weiner; J A Martial
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

4.  Mutation in the Jak kinase JH2 domain hyperactivates Drosophila and mammalian Jak-Stat pathways.

Authors:  H Luo; P Rose; D Barber; W P Hanratty; S Lee; T M Roberts; A D D'Andrea; C R Dearolf
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

5.  JAK2 is required for induction of the murine DUB-1 gene.

Authors:  R Jaster; Y Zhu; M Pless; S Bhattacharya; B Mathey-Prevot; A D D'Andrea
Journal:  Mol Cell Biol       Date:  1997-06       Impact factor: 4.272

6.  Methylation and microRNA-mediated epigenetic regulation of SOCS3.

Authors:  Chandra S Boosani; Devendra K Agrawal
Journal:  Mol Biol Rep       Date:  2015-04       Impact factor: 2.316

7.  JAK2 activates TFII-I and regulates its interaction with extracellular signal-regulated kinase.

Authors:  D W Kim; B H Cochran
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272

8.  Short stature in partially corrected X-linked severe combined immunodeficiency--suboptimal response to growth hormone.

Authors:  Suk See De Ravin; Elaine Shum; Kol A Zarember; Geoffrey Rezvani; Ron G Rosenfeld; Constantine A Stratakis; Harry L Malech
Journal:  J Pediatr Endocrinol Metab       Date:  2008-11       Impact factor: 1.634

9.  CNTF-evoked activation of JAK and ERK mediates the functional expression of T-type Ca2+ channels in chicken nodose neurons.

Authors:  Thomas Trimarchi; Judith Pachuau; Andrew Shepherd; Deblina Dey; Miguel Martin-Caraballo
Journal:  J Neurochem       Date:  2008-11-21       Impact factor: 5.372

10.  yuDetecting the percent of peripheral blood mononuclear cells displaying p-STAT-3 in malignant glioma patients.

Authors:  William Humphries; Yongtao Wang; Wei Qiao; Chantal Reina-Ortiz; Mohamed K Abou-Ghazal; Lamonne M Crutcher; Jun Wei; Ling-Yuan Kong; Raymond Sawaya; Ganesh Rao; Jeffrey Weinberg; Sujit S Prabhu; Gregory N Fuller; Amy B Heimberger
Journal:  J Transl Med       Date:  2009-11-09       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.